At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
STRYKER SUSTAINABILITY SOLUTIONS PULSE OXIMETERSdevice
Likely dose
Reprocessed noninvasive pulse oximeter sensorsAI-extracted
Key inclusion· 3
- ✓Good general health with no evidence of pre-existing medical problems
- ✓Fluent in both written and spoken English
- ✓Able to review informed consent and willing to comply with study procedures
Key exclusion· 12
- ✕Obesity (BMI >30)
- ✕History of heart disease, lung disease, kidney disease, or liver disease
- ✕Prior asthma, sleep apnea, or current CPAP use
- ✕Diabetes
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
SpO2 Accuracy of Noninvasive Disposable Pulse Oximeter Sensor With Motion Conditions
In Brief
A clinical study evaluating STRYKER SUSTAINABILITY SOLUTIONS PULSE OXIMETERS for Healthy and Hypoxia. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The purpose of this clinical study is to validate the SpO2 accuracy of the Stryker Sustainability Solutions pulse oximetry sensors during motion conditions over the range of 70-100% SaO2 as compared to arterial blood samples assessed by CO-Oximetry. The end goal is to provide supporting documentation for the SpO2 accuracy validation of the reprocessed sensors.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsUniversity of California, San Francisco
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartFeb 2022
Primary CompletionFeb 2022
First PostedMar 2022
TodayJul 2026
First PostedMar 3, 2022
Enrollment StartFeb 2, 2022
Primary CompletionFeb 3, 2022
TodayJul 2, 2026
Enrollment to primary: 1 daysPosted 4.3 years ago
Interventions
STRYKER SUSTAINABILITY SOLUTIONS PULSE OXIMETERSdevice
Reprocessed noninvasive pulse oximeter sensors.